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INTRODUCTION
Sepsis-associated encephalopathy (SAE) is a poorly
understood and underdiagnosed neurological complication
of sepsis. Several conditions commonly associated with
sepsis (hepatic or renal dysfunction, electrolyte abnormali-
ties, acid-base disturbances, glycemia disturbances, hypo-
tension, hypoxemia, sedation, body temperature distur-
bances, and neuroendocrine dysfunction) make SAE evalu-
ation difficult.
Sepsis-associated encephalopathy has been reported to
occur in 8% to 70% of septic patients. This large range de-
rives from the different definitions of sepsis and encepha-
lopathy used in the current literature.1 In some cases, SAE
may precede other manifestations of sepsis.2 We report a case
of a 37-year-old pregnant woman who developed septic en-
cephalopathy for whom the initial symptom was confusion
that evolved with motor deficit and subsequently to coma.
CASE REPORT
A 37-year-old woman, 27-weeks pregnant, was trans-
ferred to the emergency department of Hospital das Clínicas
de São Paulo due to altered mental status. According to her
husband, approximately 3 hours earlier that morning soon
after she woke up, the patient was confused and repeatedly
uttering inappropriate words.
The patient had had 2 previous hospitalizations in the
previous 2 months for investigation of anasarca. On exami-
nation, an abdominal ultrasonography revealed dilated por-
tal system veins, hepatomegaly with left lobe predomi-
nance, and splenomegaly.
During the same hospitalization, a feces exam was per-
formed (Table 1), and the diagnosis of portal system hyper-
tension and nephrotic syndrome due to schistosomiasis was
made. Moreover, she presented anemia secondary to the ne-
phrotic syndrome and pyelonephritis by Enterococcus sp. She
was discharged to her home taking furosemide 40 mg/d,
enoxaparin 40 mg/d, vitamins, and alimentary supplements
(folic acid, B-complex vitamins, and ferrous sulfate). It was
her fourth gestation, and the previous ones had evolved well;
her children were 15, 10, and 7 years old.
After 3 days, she was transferred again to the hospital.
Day 1. At physical examination, the following was ob-
served: Glasgow Coma Scale (GCS) = 13 (best eye re-
sponse (BER) = 4, best motor response (BMR) = 6, best
verbal response (BVR) = 3); isocoric pupils with a prompt
reaction to light and no focal neurological signs; jaundice,
2+/4; pale mucosa; and edematous limbs. Her heart rate
was 120 bpm, blood pressure was normal (130 x 80 mm
Hg), lung auscultation was normal, and she was eupneic.
The measurement of uterine fundal height was 20 cm and
fetal heart sounds were present. On the same day, there was
a decreased GCS to 9 (BER = 2, BMR = 5, BVR= 2), but
without other alterations of the physical examination. A cra-
nial computed tomography (CT) was performed with nor-
mal results. After the CT procedure, cerebrospinal fluid was
obtained (Table 2).
Day 2. The patient remained with normal blood pres-
Table 1 - Laboratory exams
Normal Range Results
Blood
Ammonia (µg/dL) 19-87 56
Thyroxine free (ng/dL) 0.7-1.5 0.84
TSH* (µU/mL) 0.4-4.5 1.55
Feces
Kato-Katz# (eggs/g of feces) 0 24
* TSH: thyroid stimulating hormone
# Kato-Katz: egg counts of Schistosoma mansoni – Kato-Katz technique
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sure, and her heart rate was 125 bpm. However, GCS de-
creased to 8 (BER = 2, BMR = 4, BVR = 2), downward
conjugate movement of the eyes was noticed as well as in-
complete right hemiparesis, even though sedatives were not
used. The patient was transferred to the intensive care unit,
and sedation with midazolam was performed to carry out
an orotracheal intubation. Soon after orotracheal intubation,
the blood pressure was normal, and cultures of blood and
urine were collected. Laboratory results are listed in Ta-
bles 1 and 3. Intravenous fluid was administrated due to
worsening renal function (Table 3). The chest x-ray re-
vealed alveolar infiltrates in the left lower lobe.
Day 3. At 11:30 AM, the obstetric ultrasonographic ex-
amination revealed fetal death. Neurologic examination re-
mained the same and the blood pressure was 136 x 100
mmHg.
Day 4. At 00:30 AM, she presented agitation, high
blood pressure (168 x 100 mm Hg), tachycardia (163 beats
per minute), tremor, and sweating. This was followed by
fever (37.9oC) and hypotension (80 x 40 mm Hg), with
prompt response to infusion of 2 liters of crystalloids. On
the same day, purulent tracheal sputum was noticed, asso-
ciated with a decrease in the PaO2/FiO2 ratio (Table 3). An-
tibiotic therapy was introduced, initially with cefepime plus
clindamycin, to treat possible lung or pelvic infections. At
3:30 AM, spontaneous fetal expulsion occurred; the fetus
was dead and without fetid odor. The placenta was normal.
The patient’s physical examination revealed a GCS 7T
(BER = 2, BMR = 4, BVR = 1 and T = orotracheal intu-
bation), absence of conjugate eye movement and hemipare-
sis. She was anicteric with anasarca. The electroencepha-
logram (Figure 1) suggested metabolic disturbances (excess
of slow waves and presence of triphasic waves). The mag-
netic angioresonance and cerebral parenchyma magnetic
resonance images were normal.
Day 5. The urine culture collected at day 2 was grow-
Table 3 - Daily laboratory results
Normal Range Day 1 Day 2 Day 4 Day 5 Day 8 Day 11
Sodium (mEq/L) 135-145 137 137 137 139 144 146
Potassium (mEq/L) 3.5-5.0 3 3.8 3.4 3.4 2.8 3.5
Magnesium (mg/dL) 1.58-2.55 2.58 2.58 2.24 2.05 1.83 1.76
Chloride (mEq/L) 96-105 - 106 105 108 117 116
Glucose (mg/dL) 70-100 68 98 - 96 77 81
Phosphorus (mg/dL) 2.7-4.5 - 4.7 5.1 4.1 3.1 2.8
Total Bilirubin (mg/dL) 0.2-1.0 1.9 1.7 1.5 0.8 0.6 0.6
Direct Bilirubin (mg/dL) < 0.3 1.2 1.2 1.0 0.3 0.3 0.3
Creatinine (mg/dL) 0.5-0.9 1.23 2.13 1.73 1.33 0.83 0.58
Urea Nitrogen (mg/dL) 10-50 44 61 78 78 60 45
Hemoglobin (g/dL) 12-16 11.2 11.0 11.0 9.2 9.3 8.9
Hematocrit (%) 35-47 33.6 32.3 33.2 27.5 27.9 27.1
Leucocytes/mm³ 4.000-11.000 7.190 10.570 16.620 10.020 5.090 3.950
Platelets/mm³ 140.000-240.000 243.000 257.000 235.000 81.000 81.000 134.000
LDH# (U/L) 240-480 - 941 954 961 - 853
CRP* (mg/L) <3 - 186 186 184 102 62.3
Arterial pH 7.37-7.44 - 7.512 7.481 7.462 7.457 7.458
Arterial PaO2 (mm Hg) 80-90 - 74.3 66.9 68.7 88.3 80.2
Bicarbonate (mmol/L) 20-29 - 18 15.8 19.7 20.3 19.2
Arterial PaCO2 (mm Hg) 31-42 - 22.9 21.7 41.5 29.3 19.1
Base Excess (mmol/L) -3.2 -1.2 - -2.8 -5.2 -2.6 -2.3 -3.1
PaO2/FiO2 Ratio >400 - 353 111 114 294 382
Arterial Lactate (mg/dL) 4.5-14 - 37 47 28 19 18
APTT (seconds) 21-29 27.3 29.2 31 30.1 31 -
PT (seconds) 12 11.7 12.0 14 14 13.5 -
Total Proteins (g/dL) 6.6-8.7 3.7 3.6 3.8 - 3.0 3.5
Albumin (g/dL) 3.4-4.8 1.4 1.3 1.1 - 0.9 1.0
AST (U/L) < 31 91 94 87 76 64 124
ALT (U/L) < 31 63 60 54 42 40 62
* CRP: C-reactive protein; # LDH: Lactic dehydrogenase
Table 2 - Cerebrospinal fluid
Normal Range Results
Cells: ≤ 5 cells/mm³ 1/mm³




Proteins: ≤ 40 mg/dL 13 mg/dL
Glucose: 50-90 mg/dL 42 mg/dL
Chloride: 118-140 mEq/L 123 mEq/L
Cultures: negatives negatives
Indian Ink: negative negative
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ing Citrobacter freundii (90%) and Klebsiella pneumoniae
(10%), both cefepime sensitive; and a blood culture iden-
tified a coagulase-negative Staphylococcus. Oxacillin was
introduced, and clindamycin was interrupted. The absence
of remaining placenta was revealed by pelvic ultrasonog-
raphy; however, there was mild ascites.
Day 7, The GCS was 9T (BER = 3, BMR = 5, BVR =
1, and T = orotracheal intubation), and ventilator weaning
was initiated.
Day 8. Mechanical ventilation was successfully discon-
tinued, and GCS was 11 (BER = 4, BMR = 6, BVR = 1).
Day 11. The patient’s mental status improved and she
was discharged from the intensive care unit. Her neurologi-
cal physical examination was normal.
After discharge from the intensive care unit. A kid-
ney biopsy and histopathology were performed revealing
membrano-proliferative glomerulonephritis type III; im-
munofluorescence was positive for IgM and C3 after treat-
ment with antiprotein serums. The histopathology and im-
munofluorescence findings were suggestive of nephropa-
thy secondary to schistosomiasis.
Figure 1 - Electroencephalogram pattern showing diffuse cerebral
involvement, with slow waves being predominantly delta waves, frequently
in a triphasic pattern, mainly at front and sides
DISCUSSION
This patient with altered mental status was promptly
investigated for possible differential diagnoses. First, an
acute ischemic stroke or central venous thrombosis were
the main diagnostic hypothesis based on her
hypercoagulability state (nephrotic syndrome and preg-
nancy). Nevertheless, the angioresonance results were nor-
mal. As shown in the report and laboratory results tables,
we also ruled out other differential diagnoses, such as
hypoglycemia, hepatic encephalopathy, uremic encepha-
lopathy, electrolyte abnormalities, and central nervous in-
fection.
Preeclampsia was ruled out because the patient pre-
sented normal blood pressure during the hospitalization
period, and the proteinuria was confirmed to be due to ne-
phropathy secondary to schistosomiasis.
The HELLP syndrome was also ruled out, since
hemolysis was not observed (mainly because schizocytes
were not found). Neither were low platelets or liver en-
zymes higher than 3 times the upper limit normality found.
The electroencephalogram (EEG) was indicative of
metabolic encephalopathy; there were clinical and labora-
tory manifestations of sepsis, and antimicrobial therapy pro-
duced positive results, all supporting a diagnosis of SAE.
The tachycardia and leucocytosis observed on day 2 con-
firmed the sepsis diagnosis, which was compatible with re-
ports in the literature of SAE preceding sepsis signs.2 The
concomitant recovery from neurologic deficits and im-
provement of leucocytes, C-reactive protein, and arterial
lactate was observed after antimicrobial therapy.
Sepsis-associated encephalopathy can be classified as
“early” or “late,” with the latter associated with multiorgan
failure, while the early form occurs before multiorgan fail-
ure develops.3 The clinical features include altered mental
status, fluctuating confusional state, inappropriate behavior,
inattention, agitation, delirium, unresponsiveness, coma,
paratonic rigidity, and peripheral nerve dysfunction. Less
commonly seen are asterixis, cranial nerve dysfunction,
myoclonus, lateralization, tremor, and seizures.3 Most pa-
tients who survive present neurological improvement, on
average after 5 days, with a range of 2 to 10 days.4
Diagnosis of SAE is dependent on the exclusion of other
possible causes of brain dysfunction. The EEG is the most
sensitive test for SAE, even before clinical findings. A
study5 identified 5 classes of progressively worsened EEG
patterns related to worsening outcome: 1 = normal EEG,
2 = excessive theta, 3 = predominant delta, 4 = triphasic
waves, 5 = suppression or burst suppression, in ascending
order of severity. Cerebrospinal fluid analysis is generally
normal or with mild protein elevation.
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The pathophysiology of SAE is still incompletely un-
derstood; it seems to be multifactorial and not due to di-
rect infection of the central nervous system or to the pres-
ence of toxins. It involves inflammatory mediators or re-
sponse of the brain cells to these mediators. Several stud-
ies with animal models or human necropsies have shown
cerebral abnormalities, such as ischemic lesions, dissemi-
nated microinfarcts, peri-microvessel edema, brain purpura,
central pontine myelinolysis, and multifocal necrotizing
leucoencephalopathy.6 Septis-associated encephalopathy
seems to be a result of reduced cerebral blood flow and
oxygen extraction by the brain, cerebral edema, and dis-
ruption of the bloodbrain barrier that may arise from the
action of inflammatory mediators on the cerebrovascular
endothelium, abnormal neurotransmitter composition of the
reticular activating system, impaired astrocyte function, and
neuronal degeneration by apoptosis.7
This is the first report of a pregnant woman with SAE.
In cases classified as early, the neurologic symptoms may
be more evident than the signs of sepsis; therefore, SAE
should be considered in the differential diagnosis. The pres-
ence and severity of SAE correlates with mortality.1,3 Cur-
rently, a specific treatment for SAE does not exist, and a
positive neurologic outcome is dependent upon the ad-
equate treatment of sepsis.
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